Bright Minds Biosciences Inc. (DRUG) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of Bright Minds Biosciences Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRUG
Bright Minds Biosciences Inc.
$48.53HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
OVID
Ovid Therapeutics Inc.
$2.41HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — DRUG vs OVID
growth of $100 · dividends reinvested · last 6yDRUG +84.4% (+10.7%/yr)OVID -45.3% (-9.6%/yr)DRUG compounded faster over this window
DRUG OVID
DRUG vs OVID: by the numbers
- •DRUG is the larger company ($475M vs $449M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -2178.90% net margin).
Metrics side by side
Valuation
| Metric | DRUG | OVID |
|---|---|---|
| P/S ratio | N/A | 283.56 |
| P/B ratio | 2.19 | 2.14 |
Profitability
| Metric | DRUG | OVID |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -585.20% |
| Net margin | 0.00% | -2178.90% |
| ROE | -8.21% | -16.43% |
| ROIC | -13.15% | -26.29% |
Growth (annualized)
| Metric | DRUG | OVID |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -62.76% |
| Total return CAGR (5Y) | 6.76% | -6.98% |
Frequently asked
- How have DRUG and OVID total returns compared?
- Over the past 5 years, DRUG delivered 6.76% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.